Pediatrix Medical Group, Inc.
Pediatrix Medical Group, Inc., together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States and Puerto Rico. It offers neonatal care services, such as clinical…
Medical - Care Facilities
US, Sunrise [HQ]
Insiders
Transactions
Track non-derivative insider transactions.
i = Indirect Ownership
d = Direct Ownership
cs = Common Stock
| Reported Owner(s) | Position Now | Transaction Date | Type | Position Change | Extra | ||
|---|---|---|---|---|---|---|---|
|
$54,869
d
cs
10% Holder
|
12/01/24 |
A
|
11,112 x $0 = $0 |
Footnotes
#1 Restricted shares granted pursuant to the Issuer's Amended and Restated 2008 Incentive Compensation Plan (the "Plan"), in connection with an annual equity award. Twenty-five percent (25%) of the restricted shares will vest on June 1, 2025, twenty-five percent (25%) of the restricted shares will vest on June 1, 2026 and fifty percent (50%) of the restricted shares will vest on June 1, 2027, subject to the terms of the Plan.
|
|||
|
$138,683
d
cs
10% Holder
|
11/13/24 |
S
|
27,600 x $15.35 = $423,660.00 |
Footnotes
#1 The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions with prices ranging from $15.17 to $15.52 for a weighted average sales price of $15.35. The reporting person
undertakes to provide the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each seperate price within the range set forth in
this footnote.
|
|||
|
$135,810
d
cs
10% Holder
|
11/08/24 |
S
|
8,108 x $16.00 = $129,728.00 |
Footnotes
#1 The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions with prices ranging from $16.00 to $16.03 for a weighted average sales price of $16.00. The reporting person undertakes to provide the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each seperate price within the range set forth in this footnote.
|
|||
|
$170,001
d
cs
10% Holder
|
08/30/24 |
S
|
11,100 x $10.79 = $119,769.00 |
Footnotes
#1 The price reported in Colum 4 is a weighted average price. The reported securities were sold in multiple transactions with prices ranging from $10.71 to $11.00 for a weighted average sales price of $10.79. The reporting person undertakes to provide the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each price within the range set forth in this footnote.
|
|||
|
$30,805
d
cs
10% Holder
|
08/27/24 |
S
|
7,000 x $11.16 = $78,120.00 |
Footnotes
#1 The price reported in Colum 4 is a weighted average price. The reported securities were sold in multiple transactions with prices ranging from $11.16 to $11.18 for a weighted average sales price of $11.16. The reporting person undertakes to provide the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each seperate price within the range set forth in this footnote.
|
|||
Get PRO Today
With PRO you will unlock 51 more insider transactions for Pediatrix Medical Group, Inc.
Statistics
Sample Size: 56 Transactions
Sale (S)
176,885 Shares
23.21%
Buy (P)
0 Shares
0.00%
Individuals
We summarize earnings call passages, compensations, insider transactions and other information for each individual to get the bigger picture:
- Linynsky Laura A Director
- Mceachin Thomas Director
- Moore Mary Ann E EVP, GC, Chief Admin Off & Sec
- Ordan Mark S Chief Executive Officer
- Pickert Curtis EVP, Chief Operating Officer
- Richards C Marc EVP, Chief Financial Officer
- Rossi Kasandra H EVP, CFO and Treasurer
- Rucker Michael A. Director
- Sansone Guy P Director
- Starcher John M. Jr. Director
- Swift James D Chief Executive Officer
- Weis Shirley A Director
- Wood Lee EVP, Natl & Market Operations
- Young Sylvia Jean Director
Individuals
We summarize earnings call passages, compensations, insider transactions and other information for each individual to get the bigger picture:
- Linynsky Laura A Director
- Mceachin Thomas Director
- Moore Mary Ann E EVP, GC, Chief Admin Off & Sec
- Ordan Mark S Chief Executive Officer
- Pickert Curtis EVP, Chief Operating Officer
- Richards C Marc EVP, Chief Financial Officer
- Rossi Kasandra H EVP, CFO and Treasurer
- Rucker Michael A. Director
- Sansone Guy P Director
- Starcher John M. Jr. Director
- Swift James D Chief Executive Officer
- Weis Shirley A Director
- Wood Lee EVP, Natl & Market Operations
- Young Sylvia Jean Director